The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Friday, August 14, 2026

Subject of the day

BIO

Concerning the House

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

United States · www.bio-rad.com

The Long Run

FY 2010–2025 · 16 years

LineLatestCAGRTrend
Revenue$2.58B+2.0%
Gross profit$1.43B+2.7%
Operating income$47.20M-11.3%
Net income-$1.84B+19.5%
Cash from ops$532.20M+7.1%
Quotation

$361.19

-0.89 (-0.2%)

52w hi$362.08
52w lo$241.71
Vol157.44K
As ofAug 13
The Verdict

Hold

Our score +0.33

Short+0.29
Medium+0.45
Long+0.15

computed 2026-08-13

By the Numbers

Bio-Rad Laboratories, Inc.

Healthcare · Medical Devices

Market cap$9.67B
Enterprise value$9.43B
Trailing P/E43.94x
Forward P/E36.02x
EV / EBITDA21.39x
P / S (ttm)3.73x
Profit margin8.6%
Return on equity3.1%
Revenue growth-0.1%
Earnings growth+18.7%
Debt / equity19.10
Risk Metrics
Beta vs SPX0.91
Corr SPX0.36
Annual vol40.9%
Annual ret+13.0%
Sharpe0.32
Max DD-42.1%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.12
Sector+0.12
Technical+0.23
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$364.00$364.00$352.12$361.19157.44K
Aug 12$353.06$362.42$351.00$362.08233.90K
Aug 11$349.37$358.69$349.37$356.25251.90K
Aug 10$350.49$355.85$347.86$354.54221.10K
Aug 7$339.18$353.33$339.18$352.47266.90K